Therapeutic effects of molecular hydrogen for a wide range of disease models and human diseases have been investigated since 2007. A total of 321 original articles have been published from 2007 to June 2015. Most studies have been conducted in Japan, China, and the USA. About three-quarters of the articles show the effects in mice and rats. The number of clinical trials is increasing every year. In most diseases, the effect of hydrogen has been reported with hydrogen water or hydrogen gas, which was followed by confirmation of the effect with hydrogen-rich saline. Hydrogen water is mostly given ad libitum. Hydrogen gas of less than 4 % is given by inhalation. The effects have been reported in essentially all organs covering 31 disease categories that can be subdivided into 166 disease models, human diseases, treatment-associated pathologies, and pathophysiological conditions of plants with a predominance of oxidative stress-mediated diseases and inflammatory diseases. Specific extinctions of hydroxyl radical and peroxynitrite were initially presented, but the radical-scavenging effect of hydrogen cannot be held solely accountable for its drastic effects. We and others have shown that the effects can be mediated by modulating activities and expressions of various molecules such as Lyn, ERK, p38, JNK, ASK1, Akt, GTP-Rac1, iNOS, Nox1, NF-κB p65, IκBα, STAT3, NFATc1, c-Fos, and ghrelin. Master regulator(s) that drive these modifications, however, remain to be elucidated and are currently being extensively investigated.

Keywords: Molecular hydrogen, Ischemia-reperfusion injury, Inflammatory diseases


It has been 8 years since Ohsawa and colleagues reported the astonishing therapeutic effects of molecular hydrogen on a rat model of cerebral infarction in Nature Medicine in 2007 []. Inhalation of 1–4 % hydrogen gas markedly reduced the sizes of cerebral infarction in rats. They also demonstrated that hydrogen specifically scavenges hydroxyl radical and peroxynitrite but not hydrogen peroxide or superoxide. Their paper ignited interest in the effect of molecular hydrogen in various diseases and has been cited 533 times as of July 2015. Similarly, the number of original articles demonstrating the effect of molecular hydrogen adds up to more than 300. This review summarizes research articles published in these past 8 years and addresses possible molecular mechanisms underlying the effects of hydrogen.

Molecular hydrogen research before 2007

Even before the publication by Ohsawa and colleagues in 2007 [], biological effects of molecular hydrogen had been investigated in a small scale, as shown below. Dole and colleagues first reported the hydrogen effect in Science in 1975 []. They placed nude mice carrying squamous cell carcinoma in a chamber with 2.5 % oxygen and 97.5 % hydrogen under 8-atmospheric pressure and observed prominent reduction in the size of the tumors. A similar effect of hyperbaric hydrogen on leukemia was reported in 1978 []. Hydreliox, which contained 49 % hydrogen, 50 % helium, and 1 % oxygen, was reported to be effective to prevent decompression sickness and nitrogen narcosis for divers working below 500 meters under sea level []. An anti-inflammatory effect of hyperbaric hydrogen on a mouse model of schistosomiasis-associated chronic liver inflammation was also reported in 2001 []. Hyperbaric hydrogen may be effective for some diseases, but only a limited number of studies have been published. The difference between hyperbaric and normobaric hydrogen has not been directly compared to date.

Following a small number of studies with hyperbaric hydrogen, the effect of electrolytically alkaline water has been reported. Shirahata and colleagues hypothesized that the hydrogen atom, which they called active hydrogen, is generated in electrolysis and proposed that active hydrogen scavenges reactive oxygen species (ROS) []. Although it is unlikely that atomic hydrogen is able to exist for a substantial time in our bodies, molecular hydrogen does exist in electrolyzed water and the effects of electrolyzed water have been reported thereafter. Li and colleagues reported that electrolyzed water scavenged ROS and protected a hamster pancreatic beta cell line from alloxan-induced cell damage []. Similarly, reduced hemodialysis solution produced by an electrolysis device (Nihon Trim Co. Ltd.) ameliorated oxidative stress in hemodialysis patients []. In 2005, researchers in Tohoku University Graduate School of Medicine and Nihon Trim started cooperative clinical studies and established the Association of Electrolyzed Water-Hemodialysis Study Group in 2008. According to personal communications with this group, they now believe that the effects of electrolyzed water are likely due to dissolved hydrogen molecules.

In 2005, Yanagihara and colleagues at Miz Co. Ltd. reported that hydrogen-rich neutral water that was produced with their unique electrolysis device reduced oxidative stress in rats []. This was a pioneering work, because they explicitly proved that molecular hydrogen but not alkaline in the electrolyzed alkaline water exerts therapeutic effects.

Molecular hydrogen research in and after year 2007

As stated in the introduction, the Nature Medicine paper in 2007 [] spurred interest in hydrogen research. Figure Figure11 shows 321 original articles up to June 2015 in the MEDLINE database, which demonstrate the effects of molecular hydrogen on disease models, human diseases, treatment-associated pathologies, and pathophysiological conditions of plants. Most studies were conducted in Japan, China, and the USA, with a predominance of China since 2010 (Fig. 1A). About three-quarters of the articles show the effects in mice and rats (Fig. 1B), but the number of human studies is increasing every year (1 article each in 2008–2009; 2 in 2010; 3 in 2011; 5 in 2012; 9 in 2013; 6 in 2014; and 6 in 2015). In addition, the effects of hydrogen have been reported in plants in 13 articles, which suggest a wide range of effects over various species not restricted to mammals. The effects of molecular hydrogen on plants may warrant application of hydrogen to increase agricultural production. Modalities of hydrogen administration are shown in Fig. 1C. Hydrogen-rich saline, which is almost exclusively used in China, dominates over the others. Hydrogenized saline is administered either by intraperitoneal injection or drip infusion. Hydrogen water is mostly given ad libitum. Hydrogen gas is usually given by inhaling 1–4 % hydrogen gas, which is below the explosion level (4 %). There is a single report, in which hydrogen gas was injected intraperitoneally [].

An external file that holds a picture, illustration, etc.
Object name is 13618_2015_35_Fig1_HTML.jpg

Profiles of 321 original articles up to June 2015 showing therapeutic effects of molecular hydrogen. a Temporal profile of countries where the studies are reported from 2007 to June 2015. b Biological species used in the studies. cModalities of hydrogen administration to model animals, humans, and plants

Among the various routes of hydrogen administration shown in Fig. 1C, the best method still remains uncertain. This is partly because only a few reports have addressed the difference of effects among administration methods. We previously showed that drinking hydrogen water, but not continuous hydrogen gas exposure, prevented development of 6-hydorxydopamine-induced Parkinson’s disease in rats []. In addition, we recently showed that continuous exposure to hydrogen gas and ad libitum per os administration of hydrogen water modulated signaling pathways and gene expressions in different manners in mice []. We demonstrated that hydrogen-responsive genes are divided into four groups: genes that respond favorably to hydrogen gas, those that respond exclusively to hydrogen water, those that respond to both hydrogen gas and water, and those that respond only to the simultaneous administration of gas and water (Fig. 2). As hydrogen gas and water increase the hydrogen concentrations in the rodent body to a similar level [], the difference in the organs exposed to a high concentration of hydrogen, the rise time of hydrogen concentration, and/or the area under the curve of hydrogen concentration may account for the difference in the modulated genes. On the other hand, a collation of hydrogen reports indicate that a similar degree of effects can be observed with different modalities of administration. For example, the marked effect of hydrogen on a mouse model of LPS-induced acute lung injury has been reported by four different groups with three different modalities: hydrogen gas [, ], hydrogen water [], and hydrogen-rich saline [, ]. Similarly, the dramatic effect of hydrogen on animal models of acute myocardial infarction has been reported by eight different groups with two different modalities: hydrogen gas [] and hydrogen-rich saline []. To clarify the difference of hydrogen’s effects with different modalities of administration, each research group should scrutinize the difference of the effects between hydrogen gas, hydrogen water, and hydrogen-rich saline. This would uncover the best modality for each disease model, if any, and also the optimal hydrogen dose.

An external file that holds a picture, illustration, etc.
Object name is 13618_2015_35_Fig2_HTML.jpg

Four groups of genes that show different responses to hydrogen gas and/or water [] . a Bcl6 responds to hydrogen gas more than hydrogen water. b G6pc responds only to hydrogen water. c Wee1 responds to both hydrogen water and gas. d Egr1 responds only to simultaneous administration of hydrogen gas and water

Table 1 summarizes disease categories for which the effects of hydrogen have been reported. Ohsawa and colleagues reported the hydrogen effect in cerebral infarction [] and many subsequent studies also showed its effect in ischemia-reperfusion injuries including organ transplantations. Following the initial report by Ohsawa and colleagues, the specific hydroxyl radical scavenging effect of hydrogen has been repeatedly proposed in oxidative stress-mediated diseases including inflammatory diseases and metabolic diseases.

Table 1

Disease categories for which hydrogen exhibited beneficial effects

Pathophysiology No. of articles %
Oxidative stress 224 69.8
 (I/R injury 80 24.9)
 (Others 144 44.9)
Inflammation 66 20.6
Metabolism 20 6.2
Others 11 3.4

I/R ischemia/reperfusion

Table 2 shows the details of organs and diseases for which the effects of hydrogen have been reported. Table 2 is an update of our previous review article in 2012 []. We have now classified the organs and diseases into 31 categories and showed the effects in 166 disease models, human diseases, treatment-associated pathologies, and pathophysiological conditions of plants. Hydrogen is effective in essentially all organs, as well as in plants.

Table 2

Disease models, human diseases, treatment-associated pathologies, and pathophysiological conditions of plants (321 original articles published in English) for which the effects of hydrogen have been reported from 2007 to June 2015

Diseases and conditions References
Cerebrovascular diseases (CVD)
 Cerebral I/R injury [, , , , , ]
 Hypertensive stroke []
 Brain injury secondary to intracerebral hemorrhage []
 Subarachnoid hemorrhage [, , , , ]
Brain injury other than CVD
 Traumatic brain injury []
 Deep hypothermic circulatory arrest-induced brain damage []
Neurodegenerative diseases
 Parkinson’s disease [, , ]
 Alzheimer’s disease [, ]
 Restraint-induced dementia []
 Senile dementia in senescence-accelerated mice []
 LPS-induced neuroinflammation [, ]
 Oxidative stress-induced neuronal cell damage [, ]
Spinal Cord and peripheral nerve
 Spinal cord I/R injury [, ]
 Spinal cord injury [, ]
 Neuropathic pain [, , , ]
 Hyperalgesia [, , ]
 Retinal I/R injury [, ]
 Diabetic retinopathy [, ]
 Hyperoxia-induced retinopathy []
 Light-induced retinopathy [, ]
 Glutamine-induced retinopathy []
 S-nitroso-N-acetylpenicillamine-induced retinopathy []
 Optic nerve crush []
 Selenite-induced cataract []
 Corneal alkali-burn []
 Anti-inflammatory effects on LPS-activated retinal microglia cells []
 Hearing loss []
 Cisplatin-induced ototoxicity [, ]
 Ouabain-induced ototoxicity []
Oral Cavity
 Periodontitis []
 Periodontal oxidative damage []
 Lung I/R injury [, ]
 Oxygen-induced lung injury [, , ]
 Ventilation-induced lung injury [, ]
 LPS-induced acute lung injury [, , , ]
 Intestinal I/R-induced lung injury []
 Burn-induced lung injury []
 Paraquat-induced lung injury [, ]
 igarette smoking lung injury []
 Smoke inhalation lung injury []
 Pulmonary hypertension [, ]
 Myocardial infarction and I/R injury [, ]
 Diabetic cardiomyopathy []
 Sleep apnea-induced left ventricular remodeling [, ]
 Ventricular hypertrophy []
 Stress-induced gastric ulceration []
 Aspirin-induced gastric ulceration [, ]
 Intestinal I/R injury [, ]
 Ulcerative colitis [, ]
 Colon inflammation []
 Sepsis-induced intestinal injury []
 Necrotizing enterocolitis []
 Liver I/R injury [, , ]
 Chronic hepatitis B []
 Nonalcoholic steatohepatitis []
 Liver injury induced by massive hepatectomy [, , ]
 Liver injury induced by obstructive jaundice []
 Liver injury induced by endotoxin []
 Liver injury induced by acetaminophen []
 Liver injury induced by carbon tetrachloride []
 Liver injury induced by concanavalin A []
 Liver cirrhosis []
 Liver fibrosis []
 Acute pancreatitis [, ]
 Acute peritonitis []
 Renal I/R injury []
 Acute renal injury [, , ]
 Hypertensive renal injury []
 Cisplatin-induced nephropathy []
 Gentamicin-induced nephrotoxicity []
 Inhibition of AGEs production []
 Renal calcium deposition []
 Interstitial cystitis []
Reproductive organ
 Testicular I/R injury [, ]
 Erectile dysfunction []
 Nicotine-induced testicular oxidative stress []
 Cigarette smoke-induced testicular damage []
 I/R injury [, ]
 UV-induced skin injury [, ]
 Acute erythematous skin disease []
 Atopic dermatitis [, ]
 Psoriasis []
 Pressure ulcer []
 Burn [, ]
 Arsenic toxicity []
Bone and Joint
 Rheumatoid arthritis [, ]
 Osteoporosis [, ]
 Bone loss induced by microgravity []
 TNFα-induced osteoblast injury []
 NO-induced cartilage toxicity []
Skeletal Muscle and soft tissue
 I/R injury in skeletal muscle []
 Inflammatory and mitochondrial myopathies []
 Muscle fatigue []
 Sports-related soft tissue injury []
Blood vessel
 Atherosclerosis [, , , , ]
 AGEs-induced blood vessel damage []
 Neointimal hyperplasia []
 Hyperplasia in arterialized vein graft []
 Vascular dysfunction []
 Vascular endothelial function []
Blood and Bone Marrow
 Aplastic anemia []
 Maintenance of multipotential stroma/mesenchymal stem cells []
 Neutrophil function []
 Inhibition of collagen-induced platelet aggregation []
 Improvement of blood fluidity []
 Diabetes mellitus []
 Hyperlipidemia [, ]
 Metabolic syndrome []
 Metabolic process-related gene expression []
 Oxidized low density lipoprotein-induced cell toxicity []
 Serum alkalinization []
 Exercise-induced metabolic acidosis []
 Sepsis [, , ]
 LPS/IFNγ-induced NO production []
 LPS-induced inflammatory response []
 LPS-induced vascular permeability [, ]
 Zymosan-induced inflammation []
 Carrageenan-induced paw edema []
 Inflammatory response of cardiopulmonary bypass []
 Type I allergy []
 Asthma []
Perinatal Disorders
 Neonatal cerebral hypoxia []
 LPS-induced fetal lung injury []
 Preeclampsia [, ]
 Growth of tongue carcinoma cells []
 Fe-NTA-induced nephrotoxicity and tumor progression []
 Radiation-induced thymic lymphoma []
 Tumor angiogenesis []
 Enhancement of 5-FU antitumor efficacy []
 Cardiac damage []
 Lung damage []
 Testicular damage []
 Skin damage [, ]
 Germ, hematopoietic and other cell damage []
 Radiation-induced adverse effects []
 Radiation-induced immune dysfunction []
 Carbon monoxide []
 Sevoflurane [, ]
 Doxorubicin-induced heart failure []
 Melamine-induced urinary stone []
 Chlorpyrifos-induced neurotoxicity []
 Heart [, ]
 Lung [, , ]
 Kidney [, ]
 Intestine [, , ]
 Pancreas []
 Osteochondral grafts []
 Acute GVHD [, ]
 Cardiac arrest [, ]
 Hemorrhagic shock [, , ]
 Hemodialysis []
 Peritoneal dialysis [, ]
 Lifespan extension []
 Sperm motility []
 Decompression sickness []
 Genotoxicity and mutagenicity []
 Root organogenesis [, ]
 Salt tolerance [, ]
 Postharvest ripening []
 Stomatal closure []
 Radish sprout tolerance to UVA []
 High light stress []
 Phytohormone signaling and stress responses []
 Tolerance to paraquat-induced oxidative stress []
 Cadmium toxicity [, ]
 Mercury toxicity []

Molecular mechanisms of the effects of hydrogen

Collation of the 321 original articles reveals that most communications address the anti-oxidative stress, anti-inflammatory, and anti-apoptotic effects. Specific scavenging activities of hydroxyl radical and peroxynitrite, however, cannot fully explain the anti-inflammatory and anti-apoptotic effects, which should involve a number of fine-tuned signaling pathways. We have shown that hydrogen suppresses signaling pathways in allergies [] and inflammation [] without directly scavenging reactive oxygen/nitrogen species. Signaling molecules that are modulated by hydrogen include Lyn [, ], Ras [], MEK [, ], ERK [, , ], p38 [, , , , , , , ], JNK [, , , , , , , , ], ASK1 [, ], Akt [, , , , , ], GTP-Rac1 [], iNOS [, , , ], Nox1 [], NF-κB p65 or NF-κB [, , , , , , , , ], IκBα [, , , , , , , , ], STAT3 [, , ], NFATc1 [, , ], c-Fos [], GSK-3β [, ], ROCK []. Activities and expressions of these molecules are modified by hydrogen. Master regulator(s) that drive these modifications remain to be elucidated.

The anti-oxidative stress effect of hydrogen was first reported to be conferred by direct elimination of hydroxyl radical and peroxynitrite. Subsequent studies indicate that hydrogen activates the Nrf2-Keap1 system. Hydrogen activates Nrf2 [, ] and its downstream heme oxygenase-1 (HO-1) [, , , , , , , ]. Kawamura and colleagues reported that hydrogen did not mitigate hyperoxic lung injury in Nrf2-knockout mice []. Similarly, Ohsawa and colleagues reported that hydrogen enhanced mitochondrial functions and induced nuclear translocation of Nrf2 at the Symposium of Medical Molecular Hydrogen in 2012 and 2013. They proposed that hydrogen induces an adaptive response against oxidative stress, which is also known as a hormesis effect. These studies indicate that the effect of hydrogen is mediated by Nrf2, but the mechanisms of how Nrf2 is activated by hydrogen remain to be solved.

Another interesting mechanism is that hydrogen modulates miRNA expressions [, ]. Hydrogen regulates expressions of miR-9, miR-21, and miR-199, and modifies expressions of IKK-β, NF-κB, and PDCD4 in LPS-activated retinal microglia cells []. Similarly, analysis of miRNA profiles of hippocampal neurons during I/R injury revealed that hydrogen inhibits I/R-induced expression of the miR-200 family by reducing ROS production, which has led to suppression of cell death []. However, modulation of miRNA expression cannot solely explain all the biological effects mediated by hydrogen. In addition, mechanisms underlying modulated miRNA expressions remain to be elucidated.

Matsumoto and colleagues reported that oral intake of hydrogen water increased gastric expression and secretion of ghrelin and that the neuroprotective effect of hydrogen water was abolished by the ghrelin receptor-antagonist and by the ghrelin secretion-antagonist []. As stated above, we have shown that hydrogen water, but not hydrogen gas, prevented development of Parkinson’s disease in a rat model []. Prominent effect of oral hydrogen intake rather than hydrogen gas inhalation may be partly accounted for by gastric induction of ghrelin.

Recently, Ohta and colleagues showed at the 5th Symposium of Medical Molecular Hydrogen at Nagoya, Japan in 2015 that hydrogen influences a free radical chain reaction of unsaturated fatty acid on cell membrane and modifies its lipid peroxidation process. Furthermore, they demonstrated that air-oxidized phospholipid that was produced either in the presence or absence of hydrogen in vitro, gives rise to different intracellular signaling and gene expression profiles when added to the culture medium. They also showed that this aberrant oxidization of phospholipid was observed with a low concentration of hydrogen (at least 1.3 %), suggesting that the biological effects of hydrogen could be explained by the aberrant oxidation of phospholipid under hydrogen exposure. Among the many molecules that are altered by hydrogen, most are predicted to be passengers (downstream regulators) that are modulated secondarily to a change in a driver (master regulator). The best way to identify the master regulator is to prove the effect of hydrogen in an in vitro system. Although, to our knowledge, the study on lipid peroxidation has not yet been published, the free radical chain reaction for lipid peroxidation might be the second master regulator of hydrogen next to the radical scavenging effect. We are also analyzing other novel molecules as possible master regulators of hydrogen (in preparation). Taken together, hydrogen is likely to have multiple master regulators, which drive a diverse array of downstream regulators and achieve beneficial biological effects against oxidative stress, inflammation, apoptosis, and dysmetabolism to name a few (Fig. 3).

An external file that holds a picture, illustration, etc.
Object name is 13618_2015_35_Fig3_HTML.jpg

Schematic summary of molecular mechanisms of hydrogen

These studies all point to the notion that hydrogen modulates intracellular signal transduction systems and regulates the downstream gene expressions to mitigate disease processes. In general, biologically active substances that modulate signaling molecules have both beneficial and noxious effects on our bodies. Hydrogen may also have undisclosed toxic effects, although none have been reported to date to the best of our knowledge. Understanding the exact molecular mechanisms of the effects of hydrogen will elucidate its master regulator(s) and clarify the pros and cons of hydrogen therapy, which will also potentially lead to the development of another therapeutic modality to modulate the master regulator(s). We summarized in Table 3 original articles that addressed biological effects and in vivo kinetics of hydrogen, which were not directly relevant to disease models or human diseases. It is essential to elucidate detailed pharmacokinetics of hydrogen in vivo from the viewpoint of clinical application of hydrogen, although we have accumulated vast knowledge about the effects and not the kinetics of hydrogen in disease models and human diseases. Through these analyses, promising outcomes are expected for more effective administration regimen of hydrogen therapy.

Table 3

Original articles showing physiological effects and in vivo kinetics of hydrogen

Biological effects and in vivo kinetics of hydrogen References
Superoxide formation in brain slices in mice []
Gene expression profiles and signal transduction pathways evaluated by DNA microarray and RNA-seq in rodents []a, [], []a, []a
Comparison of intermittent and continuous administration of hydrogen gas in rats []a
Safety of hydrogen inhalation in patients with cerebral ischemia []
A convenient method to estimate the concentration of hydrogen in water []
Hydrogen consumption in human body after hydrogen administration [, ]
Ghrelin induction and secretion by hydrogen-dissolved water in mice []a
Additive effects of hydrogen and NO [, ]a
In vivo kinetics of hydrogen after hydrogen administration in rodents [, ]
Lack of reactivity of hydrogen with peroxynitrite []
Antioxidant activity of nano-bubble hydrogen-dissolved water []
Additive effects of hydrogen gas and hydrogen-rich water []

aThese articles are also listed in Table 2

Clinical studies of molecular hydrogen

As stated in the introduction, the number of clinical trials has been increasing since 2011. About half of human studies have been conducted in Japan. Dependable studies recruiting more than ten patients or employing double-blind studies are summarized in Table 4.

Table 4

Clinical trials published as of June, 2015

Authors/Year Disease Sample size Open-label (OL), double-blind (DB), or single-blind (SB) Hydrogen administration Summary of the outcome
Kajiyama et al. []/2008 Diabetes mellitus type II 30 DB Water Improvement of fractions of low-density lipoprotein (LDL)-cholesterol and a glucose tolerance test.
Nakao et al. []/2010 Metabolic syndrome 20 OL Water Improvement of urinary markers for oxidative stress such as SOD and TBARS, and increase of high-density lipoprotein (HDL)-cholesterol.
Nakayama et al. []/2010 Chronic renal failure 29 OL Dialysis Amelioration of hypertension and improvement of markers for oxidative stress and inflammation.
Ito et al. []/2011 Inflammatory and mitochondrial myopathies 31 OL/DB Water OL: Improvement of the serum lactate/pyruvate ratio in mitochondrial myopathies and the serum matrix metalloproteinse-3 level in polymyositis/dermatomyositis.
DB: Improvement of the serum lactate.
Kang et al. []/2011 Radiation-induced adverse effects for liver tumors 49 OL Water Improvement of quality of life (QOL) scores during radiotherapy.
Reduction of blood reactive oxygen metabolites and maintenance of blood oxidation potential.
Ishibashi et al. []/2012 Rheumatoid arthritis 20 OL Water Improvement of disease activity score for rheumatoid arthritis (DAS28).
Decrease of urinary 8-OHdG.
Aoki et al. []/2012 Muscle fatigue 10 DB Water Improvement of muscle fatigue in young athletes
Li et al. []/2013 Pressure skin ulcer 22 OL Water Wound size reduction and early recovery from skin pressure ulcer.
Matsumoto et al. []/2013 Interstitial cystitis 30 DB Water No significant effect on symptoms.
Reduction of the bladder pain score in 11 % of patients.
Nagatani et al. []/2013 Cerebral ischemia 38 OL Intravenous infusion Confirmation of safety of intravenous H2 infusion.
Decrease of MDA-LDL, a serum marker for oxidative stress, in a subset of patients.
Shin et al. []/2013 UV-induced skin injury 28 OL Gas Prevention and modulation of UV-induced skin inflammation, intrinsic skin aging, and photo aging process through reduction of MMP-1, IL-6, and IL-1b mRNA expression.
Song et al. []/2013 Hyperlipidemia 20 OL Water Decrease of total serum cholesterol, LDL-cholesterol, apolipoprotein (apo) B100, and apoE
Xia et al. []/2013 Chronic hepatitis B 60 DB Water Attenuation of oxidative stress
Yoritaka et al. []/2013 Parkinson disease 17 DB Water Improvement of Total Unified Parkinson’s Disease Rating Scale (UPDRS) and exacerbation after termination of H2 water.
Ishibashi et al. []/2014 Rheumatoid arthritis 24 DB Intravenous saline infusion Improvement of DAS28.
Decrease of serum IL-6, MMP3, CRP, and urinary 8-OHdG.
Ostojic et al. []/2014 Sports-related soft tissue injury 36 SB H2-rich tablets and topical H2packs Decrease of plasma viscosity.
Faster recovery from soft tissue injury.
Ostojic et al. []/2014 Exercise-induced metabolic acidosis 52 DB Water Increased blood alkalinity in physically active men.
Sakai et al. []/2014 Vascular endothelial function. 34 DB Water Increased flow-mediated dilation of branchial artery, suggesting that H2 can serve as a modulator of vasomotor function of vasculature.
Song et al. []/2015 Hyperlipidemia 68 DB Water Down-regulation of plasma levels of total cholesterol, and LDL-cholesterol, followed by increased plasma pre-β -HDL, apoM, and decreased plasma oxidized-LDL, apoB100.

Features shared in these clinical studies are that hydrogen exhibits statistically significant effects in patients but the effects are usually not as conspicuous as those observed in rodent models. These can be accounted for by i) the difference in species, ii) technical difficulty in preparing a high concentration of hydrogen water every day for the patients, and iii) the difference between acute and chronic diseases. Further large-scale and long-term clinical studies are expected to prove the effects of hydrogen in humans.

Table 5 shows clinical studies currently registered in Japan. Researchers in Juntendo University have started a large-scale clinical trial of Parkinson’s disease after they have shown the effects of molecular hydrogen in a small number of patients in a short duration []. Being prompted by the prominent effects of hydrogen for mouse models with ischemia reperfusion injuries, clinical trials for acute post cardiac arrest syndrome and myocardial infarction have started at Keio University. Similarly, a clinical trial for cerebral infarction has started at the National Defense Medical College.

Table 5

Clinical trials registered in Japan as of June, 2015

Date Disease Affiliation Status
7/16/2008 Interstitial cystitis Koshinkai Hosp. Finished[]
8/21/2008 Impaired glucose tolerance and impaired fasting glycaemia Digestive tract internal medicine, Kyoto Prefectural University of Medicine Finished [].
7/17/2009 Mild cognitive impairment Neuropsychiatry, Tsukuba Univ. Finished
1/11/2011 Chronic hemodialysis Nephrology, Fukushima Medical University Trial in progress
6/2/2011 Acute cerebral infarction Neurosurgery, Self Defense Medical College Calling for participants[]
9/30/2011 Normal adults Faculty of Health Sciences, Kyorin Univ. Finished
12/4/2011 Acute myocardial infarction Cardiology, Keio Univ. Calling for participants
3/14/2012 Parkinson’s disease Neurology, Juntendo Univ. Finished []
10/16/2012 Multiple system atrophy, Progressive supranuclear palsy Neurology, Juntendo Univ. Trial in progress
2/13/2013 Parkinson’s disease Neurology, Juntendo Univ. Calling for participants
5/1/2013 Chronic obstructive pulmonary disease Respiratory Medicine, Juntendo Univ. Trial in progress
5/20/2013 Hepatitis and liver cirrhosis Gastroenterology and Hepatology, Okayama Univ. In preparation
11/22/2013 Post cardiac arrest syndrome Emergency and Critical care medicine, Keio Univ. Calling for participants
2/22/2014 Eye disease Ophthalmology, Nippon Medical school Finished
7/1/2014 Acute myocardial infarction Cardiology, National Center for Global Health and Medicine Calling for participants
7/29/2014 Subarachnoid hemorrhage Neurosurgery, Self Defense Medical College Calling for participants []
8/1/2014 Lung transplantation General thoracic surgery, Osaka Univ. Calling for participants
10/27/2014 Retinal artery occlusion Ophthalmology, Nippon Medical school Calling for participants
7/3/2015 Type 2 diabetes mellitus Tokyo Metropolitan Institute of Gerontology Calling for participants

The department names are shown if they are available in the UMIN clinical trial database


The number of original articles showing the effects of hydrogen are increasing yearly after 2007, and an extensive review of these articles are getting more and more difficult. Some of these articles, however, are a repetition of previous studies with insignificant novel findings. We suppose that almost all disease models and almost all modalities by which hydrogen is administered have been already examined. Large-scale controlled human studies and elucidation of molecular mechanisms underlying the effects of hydrogen are the next steps that must be pursued.

A dose–response effect of hydrogen is observed in drinking hydrogen-rich water [, ]. A similar dose–response effect is also observed in inhaled hydrogen gas [, , ]. However, when hydrogen concentrations in drinking water and in inhaled gas are compared, there is no dose–response effect. Hydrogen-rich water generally shows a more prominent effect than hydrogen gas, although the amount of hydrogen taken up by hydrogen water is ~100 times less than that given by hydrogen gas []. Gastric secretion of ghrelin may partly account for this difference []. Another factor that accounts for the effects of hydrogen is the temporal profile of hydrogen administration. Intermittent inhalation, but not continuous inhalation, of hydrogen is protective against a rat model of Parkinson’s disease, which is against a dose-responsiveness of hydrogen []. The prominent effects of molecular hydrogen in a variety of disease models, human diseases, treatment-associated pathologies, and pathophysiological conditions of plants have been disclosed in these 8 years, but unsolved conundrums still challenge us.


Works done in our laboratories were supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the Ministry of Health, Labor and Welfare (MHLW) of Japan, the Japan Agency for Medical Research and Development (AMED), and Chubu University Grants A and B.



Competing interests

We have no competing interest to disclose.



Authors’ contributions

MI1 collated and scrutinized all hydrogen papers. SS, MI2, MI3, and MH made critical comments on hydrogen papers. MI1 and KO wrote the paper. All authors read and approved the final manuscript.



1. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13(6):688–94. [PubMed] []
2. Dole M, Wilson FR, Fife WP. Hyperbaric hydrogen therapy: a possible treatment for cancer. Science. 1975;190(4210):152–4. [PubMed] []
3. Roberts BJ, Fife WP, Corbett TH, Schabel FM., Jr Response of five established solid transplantable mouse tumors and one mouse leukemia to hyperbaric hydrogen. Cancer Treat Rep. 1978;62(7):1077–9. [PubMed] []
4. Abraini JH, Gardette-Chauffour MC, Martinez E, Rostain JC, Lemaire C. Psychophysiological reactions in humans during an open sea dive to 500 m with a hydrogen-helium-oxygen mixture. J Appl Physiol. 1994;76(3):1113–8. [PubMed] []
5. Gharib B, Hanna S, Abdallahi OM, Lepidi H, Gardette B, De Reggi M. Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation. C R Acad Sci III. 2001;324(8):719–24. [PubMed] []
6. Shirahata S, Kabayama S, Nakano M, Miura T, Kusumoto K, Gotoh M, et al. Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage. Biochem Biophys Res Commun. 1997;234(1):269–74. [PubMed] []
7. Li Y, Nishimura T, Teruya K, Maki T, Komatsu T, Hamasaki T, et al. Protective mechanism of reduced water against alloxan-induced pancreatic beta-cell damage: Scavenging effect against reactive oxygen species. Cytotechnology. 2002;40(1–3):139–49. [PMC free article] [PubMed] []
8. Huang KC, Yang CC, Lee KT, Chien CT. Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water. Kidney Int. 2003;64(2):704–14. [PubMed] []
9. Yanagihara T, Arai K, Miyamae K, Sato B, Shudo T, Yamada M, et al. Electrolyzed hydrogen-saturated water for drinking use elicits an antioxidative effect: a feeding test with rats. Biosci Biotechnol Biochem. 2005;69(10):1985–7.[PubMed] []
10. Huang G, Zhou J, Zhan W, Xiong Y, Hu C, Li X, et al. The neuroprotective effects of intraperitoneal injection of hydrogen in rabbits with cardiac arrest. Resuscitation. 2013;84(5):690–5. [PubMed] []
11. Ito M, Hirayama M, Yamai K, Goto S, Ito M, Ichihara M, et al. Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson’s disease in rats. Med Gas Res. 2012;2(1):15. [PMC free article] [PubMed] []
12. Sobue S, Yamai K, Ito M, Ohno K, Ito M, Iwamoto T, et al. Simultaneous oral and inhalational intake of molecular hydrogen additively suppresses signaling pathways in rodents. Mol Cell Biochem. 2015;403(1–2):231–41.[PubMed] []
13. Qiu X, Li H, Tang H, Jin Y, Li W, Sun Y, et al. Hydrogen inhalation ameliorates lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2011;11(12):2130–7. [PubMed] []
14. Xie K, Yu Y, Huang Y, Zheng L, Li J, Chen H, et al. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis. Shock. 2012;37(5):548–55. [PubMed] []
15. Hattori Y, Kotani T, Tsuda H, Mano Y, Tu L, Li H, et al. Maternal molecular hydrogen treatment attenuates lipopolysaccharide-induced rat fetal lung injury. Free Radic Res. 2015;49:1026–1037. [PubMed] []
16. Zhang Y, Liu Y, Zhang J. Saturated hydrogen saline attenuates endotoxin-induced lung dysfunction. J Surg Res. 2015;198:41–9. [PubMed] []
17. Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, Kimura K, et al. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 2008;373(1):30–5. [PubMed] []
18. Sakai K, Cho S, Shibata I, Yoshitomi O, Maekawa T, Sumikawa K. Inhalation of hydrogen gas protects against myocardial stunning and infarction in swine. Scand Cardiovasc J. 2012;46(3):183–9. [PubMed] []
19. Yoshida A, Asanuma H, Sasaki H, Sanada S, Yamazaki S, Asano Y, et al. H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs. Cardiovasc Drugs Ther. 2012;26(3):217–26. [PubMed] []
20. Shinbo T, Kokubo K, Sato Y, Hagiri S, Hataishi R, Hirose M, et al. Breathing nitric oxide plus hydrogen gas reduces ischemia-reperfusion injury and nitrotyrosine production in murine heart. Am J Physiol Heart Circ Physiol. 2013;305(4):H542–50. [PubMed] []
21. Sun Q, Kang Z, Cai J, Liu W, Liu Y, Zhang JH, et al. Hydrogen-rich saline protects myocardium against ischemia/reperfusion injury in rats. Exp Biol Med (Maywood) 2009;234(10):1212–9. [PubMed] []
22. Zhang Y, Sun Q, He B, Xiao J, Wang Z, Sun X. Anti-inflammatory effect of hydrogen-rich saline in a rat model of regional myocardial ischemia and reperfusion. Int J Cardiol. 2011;148(1):91–5. [PubMed] []
23. Jing L, Wang Y, Zhao XM, Zhao B, Han JJ, Qin SC, et al. Cardioprotective Effect of Hydrogen-rich Saline on Isoproterenol-induced Myocardial Infarction in Rats. Heart Lung Circ. 2015;24(6):602–10. [PubMed] []
24. Zhang G, Gao S, Li X, Zhang L, Tan H, Xu L, et al. Pharmacological postconditioning with lactic acid and hydrogen rich saline alleviates myocardial reperfusion injury in rats. Sci Rep. 2015;5:9858. [PMC free article][PubMed] []
25. Ohno K, Ito M, Ichihara M, Ito M. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev. 2012;2012:353152. [PMC free article] [PubMed] []
26. Itoh T, Fujita Y, Ito M, Masuda A, Ohno K, Ichihara M, et al. Molecular hydrogen suppresses FcepsilonRI-mediated signal transduction and prevents degranulation of mast cells. Biochem Biophys Res Commun. 2009;389(4):651–6. [PubMed] []
27. Itoh T, Hamada N, Terazawa R, Ito M, Ohno K, Ichihara M, et al. Molecular hydrogen inhibits lipopolysaccharide/interferon gamma-induced nitric oxide production through modulation of signal transduction in macrophages. Biochem Biophys Res Commun. 2011;411(1):143–9. [PubMed] []
28. Manaenko A, Lekic T, Ma Q, Zhang JH, Tang J. Hydrogen inhalation ameliorated mast cell-mediated brain injury after intracerebral hemorrhage in mice. Crit Care Med. 2013;41(5):1266–75. [PMC free article] [PubMed] []
29. Chen Y, Jiang J, Miao H, Chen X, Sun X, Li Y. Hydrogen-rich saline attenuates vascular smooth muscle cell proliferation and neointimal hyperplasia by inhibiting reactive oxygen species production and inactivating the Ras-ERK1/2-MEK1/2 and Akt pathways. Int J Mol Med. 2013;31(3):597–606. [PubMed] []
30. Cardinal JS, Zhan J, Wang Y, Sugimoto R, Tsung A, McCurry KR, et al. Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int. 2010;77(2):101–9. [PubMed] []
31. Liu Q, Shen WF, Sun HY, Fan DF, Nakao A, Cai JM, et al. Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice. Liver Int. 2010;30(7):958–68. [PubMed] []
32. Kasuyama K, Tomofuji T, Ekuni D, Tamaki N, Azuma T, Irie K, et al. Hydrogen-rich water attenuates experimental periodontitis in a rat model. J Clin Periodontol. 2011;38(12):1085–90. [PubMed] []
33. Tanaka Y, Shigemura N, Kawamura T, Noda K, Isse K, Stolz DB, et al. Profiling molecular changes induced by hydrogen treatment of lung allografts prior to procurement. Biochem Biophys Res Commun. 2012;425(4):873–9.[PMC free article] [PubMed] []
34. Sun Y, Shuang F, Chen DM, Zhou RB. Treatment of hydrogen molecule abates oxidative stress and alleviates bone loss induced by modeled microgravity in rats. Osteoporos Int. 2013;24(3):969–78. [PubMed] []
35. Xu XF, Zhang J. Saturated hydrogen saline attenuates endotoxin-induced acute liver dysfunction in rats. Physiol Res. 2013;62(4):395–403. [PubMed] []
36. Li DZ, Zhang QX, Dong XX, Li HD, Ma X. Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells. J Bone Miner Metab. 2014;32(5):494–504. [PubMed] []
37. Guo SX, Fang Q, You CG, Jin YY, Wang XG, Hu XL, et al. Effects of hydrogen-rich saline on early acute kidney injury in severely burned rats by suppressing oxidative stress induced apoptosis and inflammation. J Transl Med. 2015;13:183. [PMC free article] [PubMed] []
38. Liu X, Chen Z, Mao N, Xie Y. The protective of hydrogen on stress-induced gastric ulceration. Int Immunopharmacol. 2012;13(2):197–203. [PubMed] []
39. Chen Q, Chen P, Zhou S, Yan X, Zhang J, Sun X, et al. Hydrogen-rich saline attenuated neuropathic pain by reducing oxidative stress. Can J Neurol Sci. 2013;40(6):857–63. [PubMed] []
40. Wu F, Qiu Y, Ye G, Luo H, Jiang J, Yu F, et al. Treatment with hydrogen molecule attenuates cardiac dysfunction in streptozotocin-induced diabetic mice. Cardiovasc Pathol. 2015;24:294–303. [PubMed] []
41. Zhai Y, Zhou X, Dai Q, Fan Y, Huang X. Hydrogen-rich saline ameliorates lung injury associated with cecal ligation and puncture-induced sepsis in rats. Exp Mol Pathol. 2015;98(2):268–76. [PubMed] []
42. Sun H, Chen L, Zhou W, Hu L, Li L, Tu Q, et al. The protective role of hydrogen-rich saline in experimental liver injury in mice. J Hepatol. 2011;54(3):471–80. [PubMed] []
43. Wang C, Li J, Liu Q, Yang R, Zhang JH, Cao YP, et al. Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF-kappaB activation in a rat model of amyloid-beta-induced Alzheimer’s disease. Neurosci Lett. 2011;491(2):127–32. [PubMed] []
44. Iio A, Ito M, Itoh T, Terazawa R, Fujita Y, Nozawa Y, et al. Molecular hydrogen attenuates fatty acid uptake and lipid accumulation through downregulating CD36 expression in HepG2 cells. Med Gas Res. 2013;3(1):6. [PMC free article] [PubMed] []
45. Shin MH, Park R, Nojima H, Kim HC, Kim YK, Chung JH. Atomic hydrogen surrounded by water molecules, H(H2O)m, modulates basal and UV-induced gene expressions in human skin in vivo. PLoS One. 2013;8(4):e61696.[PMC free article] [PubMed] []
46. Liu YQ, Liu YF, Ma XM, Xiao YD, Wang YB, Zhang MZ, et al. Hydrogen-rich saline attenuates skin ischemia/reperfusion induced apoptosis via regulating Bax/Bcl-2 ratio and ASK-1/JNK pathway. J Plast Reconstr Aesthet Surg. 2015;68(7):e147–56. [PubMed] []
47. Zhang JY, Song SD, Pang Q, Zhang RY, Wan Y, Yuan DW, et al. Hydrogen-rich water protects against acetaminophen-induced hepatotoxicity in mice. World J Gastroenterol. 2015;21(14):4195–209. [PMC free article][PubMed] []
48. Hong Y, Shao A, Wang J, Chen S, Wu H, McBride DW, et al. Neuroprotective effect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt/GSK3beta signaling pathway. PLoS One. 2014;9(4):e96212. [PMC free article] [PubMed] []
49. Guo SX, Jin YY, Fang Q, You CG, Wang XG, Hu XL, et al. Beneficial effects of hydrogen-rich saline on early burn-wound progression in rats. PLoS One. 2015;10(4):e0124897. [PMC free article] [PubMed] []
50. Wei L, Ge L, Qin S, Shi Y, Du C, Du H, et al. Hydrogen-rich saline protects retina against glutamate-induced excitotoxic injury in guinea pig. Exp Eye Res. 2012;94(1):117–27. [PubMed] []
51. Abe T, Li XK, Yazawa K, Hatayama N, Xie L, Sato B, et al. Hydrogen-rich University of Wisconsin solution attenuates renal cold ischemia-reperfusion injury. Transplantation. 2012;94(1):14–21. [PubMed] []
52. Noda K, Shigemura N, Tanaka Y, Kawamura T, Hyun Lim S, Kokubo K, et al. A novel method of preserving cardiac grafts using a hydrogen-rich water bath. J Heart Lung Transplant. 2013;32(2):241–50. [PubMed] []
53. Huang CS, Kawamura T, Peng X, Tochigi N, Shigemura N, Billiar TR, et al. Hydrogen inhalation reduced epithelial apoptosis in ventilator-induced lung injury via a mechanism involving nuclear factor-kappa B activation. Biochem Biophys Res Commun. 2011;408(2):253–8. [PubMed] []
54. Song G, Tian H, Liu J, Zhang H, Sun X, Qin S. H2 inhibits TNF-alpha-induced lectin-like oxidized LDL receptor-1 expression by inhibiting nuclear factor kappaB activation in endothelial cells. Biotechnol Lett. 2011;33(9):1715–22. [PubMed] []
55. Kubota M, Shimmura S, Kubota S, Miyashita H, Kato N, Noda K, et al. Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model. Invest Ophthalmol Vis Sci. 2011;52(1):427–33. [PubMed] []
56. Ji Q, Hui K, Zhang L, Sun X, Li W, Duan M. The effect of hydrogen-rich saline on the brain of rats with transient ischemia. J Surg Res. 2011;168(1):e95–101. [PubMed] []
57. Shen L, Wang J, Liu K, Wang C, Wang C, Wu H, et al. Hydrogen-rich saline is cerebroprotective in a rat model of deep hypothermic circulatory arrest. Neurochem Res. 2011;36(8):1501–11. [PubMed] []
58. Qin ZX, Yu P, Qian DH, Song MB, Tan H, Yu Y, et al. Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-alpha/NF-kappaB pathway. Atherosclerosis. 2012;220(2):343–50. [PubMed] []
59. Song G, Tian H, Qin S, Sun X, Yao S, Zong C, et al. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice. Atherosclerosis. 2012;221(1):55–65.[PubMed] []
60. Zheng H, Yu YS. Chronic hydrogen-rich saline treatment attenuates vascular dysfunction in spontaneous hypertensive rats. Biochem Pharmacol. 2012;83(9):1269–77. [PubMed] []
61. Hong Y, Guo S, Chen S, Sun C, Zhang J, Sun X. Beneficial effect of hydrogen-rich saline on cerebral vasospasm after experimental subarachnoid hemorrhage in rats. J Neurosci Res. 2012;90(8):1670–80. [PubMed] []
62. Guo JD, Li L, Shi YM, Wang HD, Hou SX. Hydrogen water consumption prevents osteopenia in ovariectomized rats. Br J Pharmacol. 2013;168(6):1412–20. [PMC free article] [PubMed] []
63. Xiao M, Zhu T, Wang T, Wen FQ. Hydrogen-rich saline reduces airway remodeling via inactivation of NF-kappaB in a murine model of asthma. Eur Rev Med Pharmacol Sci. 2013;17(8):1033–43. [PubMed] []
64. Liu GD, Zhang H, Wang L, Han Q, Zhou SF, Liu P. Molecular hydrogen regulates the expression of miR-9, miR-21 and miR-199 in LPS-activated retinal microglia cells. Int J Ophthalmol. 2013;6(3):280–5. [PMC free article][PubMed] []
65. Li FY, Zhu SX, Wang ZP, Wang H, Zhao Y, Chen GP. Consumption of hydrogen-rich water protects against ferric nitrilotriacetate-induced nephrotoxicity and early tumor promotional events in rats. Food Chem Toxicol. 2013;61:248–54. [PubMed] []
66. Zhuang Z, Sun XJ, Zhang X, Liu HD, You WC, Ma CY, et al. Nuclear factor-kappaB/Bcl-XL pathway is involved in the protective effect of hydrogen-rich saline on the brain following experimental subarachnoid hemorrhage in rabbits. J Neurosci Res. 2013;91(12):1599–608. [PubMed] []
67. Tan YC, Xie F, Zhang HL, Zhu YL, Chen K, Tan HM, et al. Hydrogen-rich saline attenuates postoperative liver failure after major hepatectomy in rats. Clin Res Hepatol Gastroenterol. 2014;38(3):337–45. [PubMed] []
68. Zhang J, Wu Q, Song S, Wan Y, Zhang R, Tai M, et al. Effect of hydrogen-rich water on acute peritonitis of rat models. Int Immunopharmacol. 2014;21(1):94–101. [PubMed] []
69. Xin HG, Zhang BB, Wu ZQ, Hang XF, Xu WS, Ni W, et al. Consumption of hydrogen-rich water alleviates renal injury in spontaneous hypertensive rats. Mol Cell Biochem. 2014;392(1–2):117–24. [PubMed] []
70. Wang X, Yu P, Yong Y, Liu X, Jiang J, Liu D, et al. Hydrogen-rich saline resuscitation alleviates inflammation induced by severe burn with delayed resuscitation. Burns. 2015;41(2):379–85. [PubMed] []
71. Zhang CB, Tang YC, Xu XJ, Guo SX, Wang HZ. Hydrogen gas inhalation protects against liver ischemia/reperfusion injury by activating the NF-kappaB signaling pathway. Exp Ther Med. 2015;9(6):2114–20.[PMC free article] [PubMed] []
72. Shi Q, Liao KS, Zhao KL, Wang WX, Zuo T, Deng WH, et al. Hydrogen-rich saline attenuates acute renal injury in sodium taurocholate-induced severe acute pancreatitis by inhibiting ROS and NF-kappaB pathway. Mediators Inflamm. 2015;2015:685043. [PMC free article] [PubMed] []
73. Shao A, Wu H, Hong Y, Tu S, Sun X, Wu Q et al. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-kappaB Pathway and NLRP3 Inflammasome. Mol Neurobiol. 2015. doi:10.1007/s12035-015-9242-y. [PubMed]
74. Chen X, Liu Q, Wang D, Feng S, Zhao Y, Shi Y, et al. Protective Effects of Hydrogen-Rich Saline on Rats with Smoke Inhalation Injury. Oxid Med Cell Longev. 2015;2015:106836. [PMC free article] [PubMed] []
75. Kohama K, Yamashita H, Aoyama-Ishikawa M, Takahashi T, Billiar TR, Nishimura T, et al. Hydrogen inhalation protects against acute lung injury induced by hemorrhagic shock and resuscitation. Surgery. 2015;158(2):399–407.[PubMed] []
76. Ren JD, Ma J, Hou J, Xiao WJ, Jin WH, Wu J, et al. Hydrogen-rich saline inhibits NLRP3 inflammasome activation and attenuates experimental acute pancreatitis in mice. Mediators Inflamm. 2014;2014:930894. [PMC free article] [PubMed] []
77. Liu FT, Xu SM, Xiang ZH, Li XN, Li J, Yuan HB, et al. Molecular hydrogen suppresses reactive astrogliosis related to oxidative injury during spinal cord injury in rats. CNS Neurosci Ther. 2014;20(8):778–86. [PMC free article] [PubMed] []
78. Kishimoto Y, Kato T, Ito M, Azuma Y, Fukasawa Y, Ohno K, et al. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects. J Thorac Cardiovasc Surg. 2015;150:645–654.[PubMed] []
79. Zhang L, Shu R, Wang C, Wang H, Li N, Wang G. Hydrogen-rich saline controls remifentanil-induced hypernociception and NMDA receptor NR1 subunit membrane trafficking through GSK-3beta in the DRG in rats. Brain Res Bull. 2014;106:47–55. [PubMed] []
80. Xie K, Wang W, Chen H, Han H, Liu D, Wang G, et al. Hydrogen-Rich Medium Attenuated Lipopolysaccharide-Induced Monocyte-Endothelial Cell Adhesion and Vascular Endothelial Permeability via Rho-Associated Coiled-Coil Protein Kinase. Shock. 2015;44(1):58–64. [PubMed] []
81. Spulber S, Edoff K, Hong L, Morisawa S, Shirahata S, Ceccatelli S. Molecular hydrogen reduces LPS-induced neuroinflammation and promotes recovery from sickness behaviour in mice. PLoS One. 2012;7(7):e42078. [PMC free article] [PubMed] []
82. Kawamura T, Wakabayashi N, Shigemura N, Huang CS, Masutani K, Tanaka Y, et al. Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo. Am J Physiol Lung Cell Mol Physiol. 2013;304(10):L646–56.[PMC free article] [PubMed] []
83. Zhai X, Chen X, Shi J, Shi D, Ye Z, Liu W, et al. Lactulose ameliorates cerebral ischemia-reperfusion injury in rats by inducing hydrogen by activating Nrf2 expression. Free Radic Biol Med. 2013;65:731–41. [PubMed] []
84. Xie Q, Li XX, Zhang P, Li JC, Cheng Y, Feng YL, et al. Hydrogen gas protects against serum and glucose deprivationinduced myocardial injury in H9c2 cells through activation of the NFE2related factor 2/heme oxygenase 1 signaling pathway. Mol Med Rep. 2014;10(2):1143–9. [PubMed] []
85. Song G, Zong C, Zhang Z, Yu Y, Yao S, Jiao P, et al. Molecular Hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor knockout mice. Free Radic Biol Med. 2015;87:58–68. [PubMed] []
86. Li Y, Xie K, Chen H, Wang G, Yu Y. Hydrogen gas inhibits high-mobility group box 1 release in septic mice by upregulation of heme oxygenase 1. J Surg Res. 2015;196(1):136–48. [PubMed] []
87. Li Y, Li Q, Chen H, Wang T, Liu L, Wang G, et al. Hydrogen Gas Alleviates the Intestinal Injury Caused by Severe Sepsis in Mice by Increasing the Expression of Heme Oxygenase-1. Shock. 2015;44(1):90–8. [PubMed] []
88. Kawamura T, Huang CS, Peng X, Masutani K, Shigemura N, Billiar TR, et al. The effect of donor treatment with hydrogen on lung allograft function in rats. Surgery. 2011;150(2):240–9. [PubMed] []
89. Buchholz BM, Masutani K, Kawamura T, Peng X, Toyoda Y, Billiar TR, et al. Hydrogen-enriched preservation protects the isogeneic intestinal graft and amends recipient gastric function during transplantation. Transplantation. 2011;92(9):985–92. [PubMed] []
90. Chen HG, Xie KL, Han HZ, Wang WN, Liu DQ, Wang GL, et al. Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages. Int J Surg. 2013;11(10):1060–6. [PubMed] []
91. Lin Y, Zhang W, Qi F, Cui W, Xie Y, Shen W. Hydrogen-rich water regulates cucumber adventitious root development in a heme oxygenase-1/carbon monoxide-dependent manner. J Plant Physiol. 2014;171(2):1–8.[PubMed] []
92. Chen Y, Chen H, Xie K, Liu L, Li Y, Yu Y, et al. H Treatment Attenuated Pain Behavior and Cytokine Release Through the HO-1/CO Pathway in a Rat Model of Neuropathic Pain. Inflammation. 2015;38:1835–46. [PubMed] []
93. Yu J, Zhang W, Zhang R, Ruan X, Ren P, Lu B. Lactulose accelerates liver regeneration in rats by inducing hydrogen. J Surg Res. 2015;195(1):128–35. [PubMed] []
94. Wei R, Zhang R, Xie Y, Shen L, Chen F. Hydrogen Suppresses Hypoxia/Reoxygenation-Induced Cell Death in Hippocampal Neurons Through Reducing Oxidative Stress. Cell Physiol Biochem. 2015;36(2):585–98. [PubMed] []
95. Matsumoto A, Yamafuji M, Tachibana T, Nakabeppu Y, Noda M, Nakaya H. Oral ‘hydrogen water’ induces neuroprotective ghrelin secretion in mice. Sci Rep. 2013;3:3273. [PMC free article] [PubMed] []
96. Yoritaka A, Takanashi M, Hirayama M, Nakahara T, Ohta S, Hattori N. Pilot study of H(2) therapy in Parkinson’s disease: a randomized double-blind placebo-controlled trial. Mov Disord. 2013;28(6):836–9. [PubMed] []
97. Fujita K, Seike T, Yutsudo N, Ohno M, Yamada H, Yamaguchi H, et al. Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. PLoS One. 2009;4(9):e7247. [PMC free article] [PubMed] []
98. Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S. Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun. 2007;361(3):670–4. [PubMed] []
99. Chen CH, Manaenko A, Zhan Y, Liu WW, Ostrowki RP, Tang J, et al. Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. Neuroscience. 2010;169(1):402–14. [PMC free article] [PubMed] []
100. Hugyecz M, Mracsko E, Hertelendy P, Farkas E, Domoki F, Bari F. Hydrogen supplemented air inhalation reduces changes of prooxidant enzyme and gap junction protein levels after transient global cerebral ischemia in the rat hippocampus. Brain Res. 2011;1404:31–8. [PubMed] []
101. Ono H, Nishijima Y, Adachi N, Tachibana S, Chitoku S, Mukaihara S, et al. Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study. Med Gas Res. 2011;1(1):12. [PMC free article] [PubMed] []
102. Liu Y, Liu W, Sun X, Li R, Sun Q, Cai J, et al. Hydrogen saline offers neuroprotection by reducing oxidative stress in a focal cerebral ischemia-reperfusion rat model. Med Gas Res. 2011;1(1):15. [PMC free article] [PubMed] []
103. Li J, Dong Y, Chen H, Han H, Yu Y, Wang G, et al. Protective effects of hydrogen-rich saline in a rat model of permanent focal cerebral ischemia via reducing oxidative stress and inflammatory cytokines. Brain Res. 2012;1486:103–11. [PubMed] []
104. Nagatani K, Wada K, Takeuchi S, Kobayashi H, Uozumi Y, Otani N, et al. Effect of hydrogen gas on the survival rate of mice following global cerebral ischemia. Shock. 2012;37(6):645–52. [PubMed] []
105. Ge P, Zhao J, Li S, Ding Y, Yang F, Luo Y. Inhalation of hydrogen gas attenuates cognitive impairment in transient cerebral ischemia via inhibition of oxidative stress. Neurol Res. 2012;34(2):187–94. [PubMed] []
106. Nagatani K, Nawashiro H, Takeuchi S, Tomura S, Otani N, Osada H, et al. Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies. Med Gas Res. 2013;3(1):13. [PMC free article] [PubMed] []
107. Olah O, Toth-Szuki V, Temesvari P, Bari F, Domoki F. Delayed neurovascular dysfunction is alleviated by hydrogen in asphyxiated newborn pigs. Neonatology. 2013;104(2):79–86. [PubMed] []
108. Cui Y, Zhang H, Ji M, Jia M, Chen H, Yang J, et al. Hydrogen-rich saline attenuates neuronal ischemia--reperfusion injury by protecting mitochondrial function in rats. J Surg Res. 2014;192(2):564–72. [PubMed] []
109. Han L, Tian R, Yan H, Pei L, Hou Z, Hao S, et al. Hydrogen-rich water protects against ischemic brain injury in rats by regulating calcium buffering proteins. Brain Res. 2015;1615:129–38. [PubMed] []
110. Takeuchi S, Nagatani K, Otani N, Nawashiro H, Sugawara T, Wada K, et al. Hydrogen improves neurological function through attenuation of blood–brain barrier disruption in spontaneously hypertensive stroke-prone rats. BMC Neurosci. 2015;16(1):22. [PMC free article] [PubMed] []
111. Zhuang Z, Zhou ML, You WC, Zhu L, Ma CY, Sun XJ, et al. Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. BMC Neurosci. 2012;13:47. [PMC free article] [PubMed] []
112. Zhan Y, Chen C, Suzuki H, Hu Q, Zhi X, Zhang JH. Hydrogen gas ameliorates oxidative stress in early brain injury after subarachnoid hemorrhage in rats. Crit Care Med. 2012;40(4):1291–6. [PMC free article] [PubMed] []
113. Takeuchi S, Mori K, Arimoto H, Fujii K, Nagatani K, Tomura S, et al. Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial. BMC Neurol. 2014;14:176. [PMC free article][PubMed] []
114. Ji X, Liu W, Xie K, Liu W, Qu Y, Chao X, et al. Beneficial effects of hydrogen gas in a rat model of traumatic brain injury via reducing oxidative stress. Brain Res. 2010;1354:196–205. [PubMed] []
115. Eckermann JM, Chen W, Jadhav V, Hsu FP, Colohan AR, Tang J, et al. Hydrogen is neuroprotective against surgically induced brain injury. Med Gas Res. 2011;1(1):7. [PMC free article] [PubMed] []
116. Hou Z, Luo W, Sun X, Hao S, Zhang Y, Xu F, et al. Hydrogen-rich saline protects against oxidative damage and cognitive deficits after mild traumatic brain injury. Brain Res Bull. 2012;88(6):560–5. [PubMed] []
117. Ji X, Tian Y, Xie K, Liu W, Qu Y, Fei Z. Protective effects of hydrogen-rich saline in a rat model of traumatic brain injury via reducing oxidative stress. J Surg Res. 2012;178(1):e9–16. [PubMed] []
118. Dohi K, Kraemer BC, Erickson MA, McMillan PJ, Kovac A, Flachbartova Z, et al. Molecular hydrogen in drinking water protects against neurodegenerative changes induced by traumatic brain injury. PLoS One. 2014;9(9):e108034. [PMC free article] [PubMed] []
119. Fu Y, Ito M, Fujita Y, Ito M, Ichihara M, Masuda A, et al. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson’s disease. Neurosci Lett. 2009;453(2):81–5. [PubMed] []
120. Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress. Brain Res. 2010;1328:152–61.[PubMed] []
121. Nagata K, Nakashima-Kamimura N, Mikami T, Ohsawa I, Ohta S. Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice. Neuropsychopharmacology. 2009;34(2):501–8. [PubMed] []
122. Gu Y, Huang CS, Inoue T, Yamashita T, Ishida T, Kang KM, et al. Drinking hydrogen water ameliorated cognitive impairment in senescence-accelerated mice. J Clin Biochem Nutr. 2010;